SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trillium Therapeutics
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
294 39 0 TRIL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
244That slide deck didn't look to have anything new or did I miss something? atticus4paws-1/16/2019
243More anecdote (this time, Sezary), just crawling along..... s22.q4cdn.com Presscaram(o)uche-1/16/2019
24212 bits per share, and Nic does............... NOTHING.scaram(o)uche-12/20/2018
241Competitor SURF shelves its lagging me too CD47 program. FTSV, apparently havintuck-12/19/2018
240Thanks for that! I put it up at twitter, with hat tip.scaram(o)uche-12/11/2018
239TRIL - re AFMD takes a crack at MF with AFM13. Slides and pictures from NYU clisemi_infinite -12/11/2018
238Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for ittuck-11/30/2018
237No direct relevance. But wouldn't it be great if resources had been marshalscaram(o)uche-11/18/2018
236Article regarding the need to better quantify MF and SS stages. emjreviews.comsemi_infinite -11/15/2018
235Further color on the CD47 antibody+rituxan combo. Note that the TRIL's advatuck111/15/2018
234I can join you as I added more recently thinking there is not much downside but ghmm-11/13/2018
233What a lousy call I made. TRIL is weak sister amongst the 3. Is it selling in semi_infinite -11/13/2018
232Peter, Any new thoughts on TRIL, after looking at the abstracts? Any new thougBladerunner17-11/13/2018
231Shucks, and I was certain that they were going to go for the FAMOUS Fluorinov agscaram(o)uche111/5/2018
230FTSV CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma Cheerstuck-10/31/2018
229Today's the day folks..... EV of zero. Good job, Nic.scaram(o)uche110/24/2018
228FTSV rebounded to 10/4 pricing. SURF and TRIL laggards suffering the inertia ofsemi_infinite -10/11/2018
227I believe that does cover the preferred. BladerunnerBladerunner17-10/10/2018
226Parsons said to use 19.3 million as the share count That includes the preferresemi_infinite -10/10/2018
225Semi_infinite, I just spoke to Jim Parsons, CFO, a few minutes ago. The companBladerunner17110/10/2018
224Lot of guess work equals thinking so caveat emptor. It could be that plus a comsemi_infinite -10/10/2018
223Semi_infinite, That's my thinking, too. Worries about a class effect. Is Bladerunner17-10/10/2018
222Assuming that it was the CELG news leak at clinics that precipitated the sell ofsemi_infinite -10/9/2018
221Perhaps it is a leak of the Celgene cd47 trial termination. FTSV and SURF gettisemi_infinite -10/9/2018
220>>Not sure what to make of the heavy volume on 10/4 with large drop in priBiomaven-10/8/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News